| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,630,000 |
| Market
Cap: |
26.95(M) |
| Last
Volume: |
204,752 |
Avg
Vol: |
427,496 |
| 52
Week Range: |
$0.6474 - $0.6474 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
216,159 |
| Total Buy Value |
$0 |
$0 |
$0 |
$108,668 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cavanaugh Maureen |
Senior Vice President and CCOO |
• – – |
2021-05-07 |
4 |
D |
$4.43 |
$9,631 |
D/D |
(2,174) |
115,946 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2021-04-30 |
4 |
D |
$4.37 |
$2,556 |
D/D |
(585) |
96,218 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2021-03-31 |
4 |
A |
$4.49 |
$2,923 |
D/D |
651 |
123,129 |
|
- |
|
| Taveira Paul |
Director |
– • – |
2021-02-19 |
4 |
S |
$6.58 |
$197,400 |
D/D |
(30,000) |
60,401 |
|
27% |
|
| Drabik David A |
Director |
– • – |
2021-02-08 |
4 |
S |
$6.08 |
$203,346 |
D/D |
(33,445) |
51,513 |
|
24% |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2021-01-02 |
4 |
D |
$6.52 |
$12,421 |
D/D |
(1,905) |
401,058 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2020-12-31 |
4 |
A |
$5.17 |
$4,436 |
D/D |
858 |
122,478 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2020-11-10 |
4 |
AB |
$6.04 |
$18,120 |
D/D |
3,000 |
402,963 |
|
-7% |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2020-10-26 |
4 |
D |
$6.78 |
$4,461 |
D/D |
(658) |
104,280 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2020-09-30 |
4 |
A |
$5.19 |
$3,799 |
D/D |
732 |
121,680 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2020-09-30 |
4 |
A |
$5.19 |
$3,737 |
D/D |
720 |
70,777 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2020-09-30 |
4 |
A |
$5.19 |
$4,090 |
D/D |
788 |
96,803 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2020-09-30 |
4 |
A |
$5.19 |
$3,794 |
D/D |
731 |
399,963 |
|
- |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2020-09-22 |
4 |
D |
$6.08 |
$529 |
D/D |
(87) |
104,938 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2020-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
96,015 |
|
- |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2020-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
105,025 |
|
- |
|
| Rewolinski Melissa |
Director |
– • – |
2020-09-03 |
4 |
S |
$5.32 |
$75,278 |
D/D |
(14,150) |
30,621 |
|
-25% |
|
| Abt John |
Chief Quality and Operations |
• – – |
2020-09-03 |
4 |
S |
$5.27 |
$5,270 |
D/D |
(1,000) |
86,015 |
|
-25% |
|
| Chapman John C |
Director |
– • – |
2020-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,986 |
85,005 |
|
- |
|
| Lepore Patrick G |
Director |
– • – |
2020-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,986 |
240,326 |
|
- |
|
| Farber Jeffrey |
Director |
– • • |
2020-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,986 |
1,668,510 |
|
- |
|
| Taveira Paul |
Director |
– • – |
2020-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,986 |
90,401 |
|
- |
|
| Rewolinski Melissa |
Director |
– • – |
2020-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,986 |
44,771 |
|
- |
|
| Drabik David A |
Director |
– • – |
2020-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,986 |
84,958 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2020-09-01 |
4 |
AB |
$5.10 |
$15,300 |
D/D |
3,000 |
399,232 |
|
31% |
|
762 Records found
|
|
Page 4 of 31 |
|
|
